Epigenetics is being suggested as a possible interface between the genetic and environmental factors that together give rise to phenotype. In mice there exists a group of genes, known as metastable epialleles, which are sensitive to environmental influences, such as diet, and undergo molecular changes that, once established, remain for the life of the individual. These modifications are epigenetic and in some cases they survive across generations, that is, through meiosis. This is termed transgenerational epigenetic inheritance. These findings have led to the idea that similar processes might occur in humans. Although it is clear that the lifestyle of one generation can significantly influence the health of the next generation in humans, in the absence of supporting molecular data it is hard to justify the notion that this is the result of transgenerational epigenetic inheritance. What is required first is to ascertain whether genes of this type, that is genes that are sensitive to the epigenetic state, even exist in humans.
Introduction
The term 'epigenetics' was coined by Waddington in the 1950s to describe the mechanism by which multicellular organisms develop different tissue types from one genotype. Today, we recognize that this process is associated with detectable molecular marks on genes, known as epigenetic marks. These epigenetic marks take various forms, such as DNA methylation and modifications to the chromatin proteins that package the DNA, but they do not alter the primary sequence of the DNA. They do, however, affect the transcriptional activity of the underlying genes; for example, cytosine methylation of DNA correlates with transcriptional silencing, whereas methylation and/ or acetylation of some histones is associated with transcriptional activity. Epigenetics is the study of changes in gene expression that are not due to DNA sequence changes and that are relatively stable through cell division.
In mice, genes have been identified that display variable expressivity among genetically identical littermates and these variations in gene expression have been shown to correlate with differences in the epigenetic state of the locus. Once established, these differential expression states last for the life of the individual. One example of this in mice is the agouti viable yellow (A vy ) locus. Of particular interest is that this locus is sensitive to environmental factors.
Metastable Epialleles in the Mouse
Some genes in the mouse are particularly sensitive to epigenetic state and exhibit variegation (that is, different expression patterns among cells of the same type), variable expressivity in an isogenic context and transgenerational epigenetic inheritance. These are known as metastable epialleles. The A vy allele and the axin-fused (Axin Fu ) allele are two examples. The A vy allele is a dominant mutation of the murine agouti (A) locus, caused by the insertion of an intracisternal A-particle (IAP) retrotransposon approximately 100 kb upstream of the agouti coding exons [1] . Contained within this IAP is a cryptic promoter which, when active, can drive constitutive expression of the agouti gene, resulting in a yellow coat color. When the cryptic promoter is silenced, a pseudoagouti coat color is produced ( fig. 1 ). Many mice have both yellow and agouti patches, called mottled, indicating a clonal pattern of silencing, that is, variegation, in these mice. It has been shown that methylation at this promoter correlates with silencing of agouti gene expression [2] . An interesting phenotype of A vy mice is that yellow mice become obese and are more likely to become insulin-resistant [3] , whereas pseudoagouti mice remain lean throughout their lifetime. This implies that, for mice carrying the A vy allele, an individual's propensity to become obese is influenced by epigenetic gene-silencing processes.
Metastable epialleles, such as A vy , have been shown to be sensitive to environment. As discussed above, inbred mice carrying the A vy allele show a range of coat colors and the proportions of yellow, mottled and pseudoagouti mice depends on their genetic background. Experiments have shown that changing the dam's diet before and during pregnancy can significantly alter these proportions. For example, when pregnant mothers' diets were supplemented with methyl donors, there was a shift in the colors of their offspring away from yellow and towards pseudoagouti [4] . This shift was correlated with a shift towards a more highly methylated state (that is, silencing) of the A vy locus [5] . Similar experiments found that feeding genistein, found in soy milk, to heterozygous A vy mothers shifted coat color towards pseudoagouti [6] . In other words, in both cases the dietary change led to decreased disease (that is, obesity and insulin resistance) susceptibility by permanently altering the epigenome.
It has also been reported that the epigenetic state of a locus can be modified by behavioral programming. Postnatal maternal behavior in rats has been shown to alter the offspring's response to stress and this correlates with a change in the epigenetic state of the glucocorticoid receptor gene promoter in the hippocampus [7] . This is a second instance in which it appears that the epigenetic state of a gene can be influenced by environment, and that once established this state is mitotically heritable throughout the lifetime of the organism. In such a case, the epigenetic state is a record of environmental history, providing an opportunity to estimate disease risk and improve preclinical diagnosis.
Transgenerational Epigenetic Inheritance in Mice
Although epigenetic states, once established, are maintained for the life of the organism, it is rare for these states to be passed to the next generation. Between generations, the epigenetic state of the genome undergoes two dynamic reprogramming events: once in the gametes of the parent and again in the zygote. In spite of this, however, there is clear evidence in mice for transmission of an epigenetic state at a small number of loci through the gametes to the next generation. This is known as transgenerational epigenetic inheritance and was initially demonstrated at the A vy locus [2] following strong evidence for such a phenomenon obtained from a number of independent studies at other loci [8] [9] [10] . Morgan et al. [2] showed that the distribution of phenotypes among offspring was related to the phenotype of the dam. A vy dams that displayed the agouti phenotype were more likely to produce agouti mice; the converse was also true for A vy dams displaying the yellow phenotype. This effect was interpreted as the result of incomplete erasure of the epigenetic mark as it passed through the female germline. Similar transgenerational epigenetic inheritance has now been reported at two other loci [11, 12] .
Sensitivity to environment, combined with transgenerational epigenetic inheritance at the A vy locus [2, 4] , imply that the diet of a pregnant mother could not only affect her offspring's coat color and propensity for obesity, but that of their offspring as well, via transgenerational epigenetic inheritance. This was, in fact, recently demonstrated by Cropley et al. [13] . They showed that methyl donor diet supplementation can change the epigenetic state of the A vy allele in the germline and that these modifications can be retained through the epigenetic reprogramming that occurs during early embryogenesis. However, these results have been somewhat tempered by the failure of another study to detect this transgenerational effect [14] . Although information in addition to DNA sequence can be inherited from parent to offspring in mice, what is the evidence that this occurs in humans?
Evidence for Transgenerational Epigenetic Inheritance in Humans
There is little direct evidence for transgenerational epigenetic inheritance in humans, despite a number of reports describing effects that superficially appear similar. The evidence is predominantly indirect and based on epidemiological studies. One frequently cited example, the Dutch Famine Birth Cohort Study [15] , reported that offspring born during times of famine in World War II were smaller than average if maternal undernutrition occurred in the third trimester. Furthermore, the offspring of the second generation of individuals also weighed less than expected when the initial undernutrition occurred during the first trimester. Hence, the effects of the maternal undernutrition were observed in both the first and second generations.
More recently, Pembrey et al. [16] reported transgenerational responses in humans, using the Avon Longitudinal Study of Parents and Children and Överkalix cohorts. They found that paternal smoking prior to 11 years of age was associated with greater BMI at 9 years of age in their sons, but not daughters. It was also found that the paternal grandfather's food supply in the slow growth period was linked to the mortality risk ratio of grandsons only, while the paternal grandmother's food supply was associated with the mor-tality risk ratio of only the granddaughters. Hence, while transgenerational effects of maternal nutrition and environment are well recognized, this report described sex-specific, paternal transgenerational effects.
It is pertinent to note that, although the above epidemiological studies appear to demonstrate transgenerational effects induced by environmental and dietary factors, these data have not been supported by any molecular evidence. This is despite the hypothesis put forward by Pembrey et al. [16] that the reported transmissions are mediated by the X and Y sex chromosomes. Although the epidemiological evidence is tantalizing, we should resist the temptation to extrapolate from mice to humans without more convincing evidence. If, however, even a small number of human genes are found to be subject to transgenerational epigenetic inheritance, it would signal a paradigm shift in the way we think about the inheritance of phenotype. So how might we set about identifying transgenerational epigenetic inheritance in humans at the molecular level?
Identifying Metastable Epialleles in Humans
In the mouse, both of the alleles that display transgenerational epigenetic inheritance at a molecular level, A vy and Axin Fu [2, 17] , are metastable epialleles. Correlations between expression and epigenetic state have been observed at these alleles. It follows, then, that loci that demonstrate these characteristics of metastable epialleles in humans would be good candidates for transgenerational epigenetic inheritance. But how do we find metastable epialleles in humans?
Unlike laboratory mice, human populations are generally outbred, with the inherent genetic differences making it difficult to definitively determine phenotypic variation due to epigenetic causes. One way to circumvent this 'genetic noise' is to study monozygotic (MZ) twin pairs, which are considered to be genetically identical, and look for epigenetic variation between individuals in a twin pair. One could then study these loci in the general population, in particular, looking for inheritance of phenotype associated with epigenetic state. Many complex diseases, including cancer, diabetes mellitus, tuberculosis and schizophrenia display high levels of discordance among MZ twins [18, 19] and, as such, provide a convenient place to start in the search for metastable epialleles in humans. Once a cohort of twins discordant for particular phenotypes is available, what technology is available to observe epigenetic variation via a candidate gene approach?
DNA methylation, which occurs on cytosine residues in CpG dinucleotides, is the most extensively studied epigenetic modification to date, in part because of the excellent methods that have been developed to detect this change, such as bisulfite sequencing [20] . This technique enables determination of the methylation state of a DNA sequence and involves treating the DNA of interest with sodium bisulfite, which converts unmethylated cytosine residues to thymine, while methylated cytosine residues remain unchanged. Sequencing of the products allows the methylation state of the original DNA to be determined. Bisulfite sequencing has been the driving force behind recent advances in epigenetics.
Following are examples in which disruption of the normal epigenetic state of the locus of interest has been implicated in the associated disease state.
Human Disease Resulting from Aberrant Epigenetic State
A pair of Dutch MZ twin girls discordant for caudal duplication anomaly has been described in which one twin was normal, except for clinodactyly of her fifth fingers and a preauricular pit, while the other twin had complete spinal duplication from the L4 vertebrate down, as well as many other associated birth defects [21] . AXIN1 was suspected as being involved because reduced levels of Axin1 in the mouse results in a similar phenotype [22] . However, sequencing of the coding exons showed no difference between the twins. When the methylation state of the AXIN1 promoter was analyzed it was found that both twins had significantly higher methylation levels than normal controls. In addition, the affected twin had significantly higher methylation levels than her unaffected co-twin [23] , implying that methylation at the AXIN1 gene may play an important role in this disease, in the absence of genetic mutation. It is important to note that correlation does not imply causation, but nevertheless, such findings will have value in preclinical diagnosis as indicators of disease risk.
Independent of MZ twin studies, there have been reports that also indicate that disruptions in epigenetic state can result in disease, for example, obesity. Prader-Willi syndrome is a rare genetic disease that is characterized by, among other symptoms, decreased mental capacity, obesity, insatiable appetite and an increased risk of diabetes. This syndrome is generally associated with genetic mutation in a set of genes on chromosome 15, but there have been some cases reported where there is no mutation, but instead, aberrant methylation, that is, an epimutation [24] . This epimutation appears to be the result of an allele that has passed through the male germline without clearing of the silent epigenetic state previously established in the grandmother, indicative of transgenerational epigenetic inheritance. Other cases of diseases resulting from disruptions in epigenetic state have been described, such as hereditary non-polyposis colorectal cancer [25] and ␣-thalassemia [26] , however, these are not known to be associated with transgenerational epigenetic inheritance.
It has also been reported that assisted reproductive technologies, such as in vitro fertilization, are associated with an increased risk of the rare congenital imprinting disorders Beckwith-Wiedemann syndrome and Angelman syndrome in the offspring [27] . These diseases are normally associated with disruption to epigenetic gene silencing on either the paternal or maternal allele. It has been suggested that the increased risk may be due to disruption of epigenetic processes in the zygote, leading to disease. However, it remains possible that it is the result of genetic differences in the parents associated with the infertility, causing the parents to employ assisted reproductive technologies. Evidence that disruption to the epigenetic reprogramming associated with in vitro embryo manipulation can alter phenotype has come from nuclear cloning experiments carried out in mice, sheep and cattle. In many cases, the cloned offspring display large offspring syndrome [28] [29] [30] . An interesting report has shown that although mice cloned by in vitro embryo manipulation have an obese phenotype, they did not have an increased appetite, nor did they pass this obesity on to their offspring [31] , suggesting that, at least with respect to this phenotype, transgenerational epigenetic inheritance is not occurring.
Conclusion
Our understanding of epigenetics is rapidly expanding and through mouse models and new technologies, we are learning that the inheritance of phenotype is more than simply the transmission of DNA sequence from one generation to the next. It is now clear that environmental factors play a bigger role in phenotypic inheritance than was once thought. However, the evidence for transgenerational epigenetic inheritance in humans is scant. While it remains possible that sporadic or complex diseases, for example, schizophrenia and obesity, could be caused by epimutations, the notion that these epimutations are passed down from one generation to the next remains unsubstantiated. 
Discussion
Dr. Kalhan: When do we say that methylation has become permanent? Why doesn't it disappear? When demethylation occurs in the blastocyste stage, how does this affect heritable markers? Does the transcriptional regulation also involve some methylation?
Dr. Whitelaw: So the first question and the last question can perhaps be combined. How do we know which methylation marks will last and which ones won't, and we don't know. We were under the assumption that all methylation of C residues lasted for the lifetime of an organism. But environmental studies have shown that development can be modified later with respect to these things. A recent paper has come out looking at methylation occurring during transcriptional pulses down a gene [1] . In this amazing paper they show that transient methylation is seen for a matter of minutes at a promoter when the RNA polymerase comes and runs down the gene, and then that methylation pattern changes, and then when the next polymerase comes and produces a transcript, there is another change. I don't know how we are going to decipher the difference between those two types of methylation but I have no doubt that we will. As I said I think the underlying critical events are the changes to the histone molecules on the chromatin proteins and the methylation of DNA is tightly linked to those events. But those events are very heterogeneous and they have been harder for us to study. Because of the development of antibodies to say methylated histone, H3 or antibodies to methylated something else, we are starting to have the ability to better understand the relationship. So I think both are true and we will have to work hard to understand that. Now why doesn't everything get demethylated? I think the reason is twofold, and we are not really sure about this, but at the moment we think that the telomeres and the centromere of a chromosome are heavily methylated and they are silenced transcriptionally, and this is part of the structure overall of epigenetic molecules. So chromatin is not just involved in transcription, it is also involved in packaging a chromosome, and that chromosome has to have its ends, it has to line up at cell division and so on. I think there are some parts of the genome, and I would say centromeres and telomeres, where the epigenetic state must not change, you cannot release that tight chromatin state. Now genes that lie in what we call pericentromeric, peritelomeric regions adjacent to these heterochromatic ends on the center of chromosomes, I think might be the kinds of positions where you might get a metastable epiallele, you are getting kind of double signaling. There is a desire to keep you methylated and heterochromatinized, but nevertheless you are a gene and maybe you want to come on and maybe they have to clear you. So these are the kinds of regions where I think we will see metastable epialleles. The other parts of the chromosome that I think we do not want to have in an active form are retrotransposons. I don't know if you are aware that about 40% of your genome is the result of ancient retrotransposition. These are parasitic DNA elements that integrate into your genome and then get silenced epigenetically followed by mutation. Once a mutational event has happened at the retrotransposon it is permanently silent. But in the interim, before it undergoes a mutational event that inactivates it, it is good to have evolved a system which will silence that retrostransposon even in the gametes, even during this period where you want to reprogram the majority of your genome. It is very dangerous to have retrotransposons that are active because they then insert themselves throughout the genome and break up critical genes.
Dr. Ravussin: You gave us two examples of genes which are clearly methylated, basically the agouti viable yellow as well as the glucocorticoid receptor. In the twin studies you referred to, I remember reading a study in which it was shown that twins discordant for obesity had basically larger differences in total methylation. We have so few candidate genes when it comes to epigenetics, what does total methylation tell you about this? How far are we from having an epigenetic map?
Dr. Whitelaw: We are a long way from having an epigenetic map and there are a number of reasons for that. One is that there has to be a map for every different tissue type because the maps will be different. The epigenome project is orders of magnitude larger than the genome project. But the epigenome project is being undertaken now in the NIH and there is an international consortium of countries that is doing this. Regarding the twin studies, I think doing a twin study and finding that the global methylation level between the two twins is different, is not helpful. I would find it very hard to know how to interpret that.
Dr. Ravussin: It was in published in PNAS, and one of the things that they showed was that the older the pairs, the more the differences. Does this mean that things can happen later on?
Dr. Whitelaw: If you look very carefully at that paper, they had one older pair of twins. In fact it is now being studied at a different level by a group in Cambridge who are looking at the epigenome. They have some data in twins, and they see no increase in the level of difference within twin pairs with aging. So the biggest problem with that paper was that they didn't look at the same individuals that had the same underlying genotype as they aged. That is the right experiment, you can do it in a mouse; perhaps it is hard in a human. You have got to be quite careful about interpreting experiments like that.
Dr. Raju: Are we going back to the theory of Lamarck that acquired features can be inherited? Is there enough proof that epigenetics can result in certain features being acquired during one generation and passed on later? Are we validating that?
Dr. Whitelaw: I think there is very little evidence for that, and I tried to make that clear. So this is the debate really and it is very important. People get carried away with the idea that the marks that are laid down can last, in a Lamarckian sense, and be inherited through the gametes to the next generation. There are metastable epialleles where that hasn't been induced as a result of an environment. Independently, other people have shown that you can change the probability by environment. There are two papers in which they tried to combine those two studies to see whether Lamarck was right at that locus, and they both conclude differently. So one of the studies, which is in PNAS, says that there is inheritance to the next generation, but they acknowledge that that could have been because when the environmental event occurred the generation two's gametes were developing at that stage in the early fetus. So that is not really Lamarckian; it depends how you interpret Lamarck. So I think there is very poor evidence. Another paper did not even find the effect.
Dr. Yajnik: David Barker postulated that DOHaD has an epigenetic basis, thus nutritional programming is epigenetic. In the Pune Maternal Nutrition Study for the first time we have evidence of a maternal nutrient status predicting adiposity and insulin resistance in the child [1] . The two nutrients are vitamin B 12 and folate, the two methyl donors. Could you advise us how we could investigate whether this association has an epigenetic basis? We have DNA samples and have the opportunity to collect them every 6 years. We have also collected DNA sample before and after a vitamin B 12 -folic acid intervention.
Dr. Whitelaw: My advice to people in this position is to wait, because I think very soon we will have better technologies for interrogating candidate genes. Yes, in theory we can do genome-wide analysis but I think it is too early. I would hold on to that precious DNA and wait 3 or 4 years and then I think there will be better candidates, in part based on mass models in which there has been a change in folate. For example the agouti viable yellow is one reported gene, but those individual genes that have been made in various laboratories can then be interrogated genome-wide, and then you know the kind of genes that you might look at and that are involved in the phenotypes you are interested in. I think that is the safest thing.
Dr. Yajnik: There is a recent paper in on the sheep models [2] . They produced methionine deficiency in sheep by dietary manipulation of vitamin B 12 , folate, etc., and demonstrated high homocysteine levels in blood and granulose cells and follicular fluid. The eggs were fertilized in vitro, and blastocysts were transferred to a normally nourished mother. The offspring had normal birthweights, but the male sheep grew rapidly, became adipose and insulin-resistant. Molecular investigations showed altered methylation at over 50 sites, half of which were male-specific. The phenotype of male offspring is very similar to our human findings. This is a very clear demonstration that periconceptional nutrition influences epigenetic changes.
